{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T15:21:32Z","timestamp":1778167292573,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.humpath.2015.09.033","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T17:57:08Z","timestamp":1445795828000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified"],"prefix":"10.1016","volume":"48","author":[{"given":"Jenny C.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Chisholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Arber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasodha","family":"Natkunam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger A.","family":"Warnke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Ohgami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.09.033_bb0005","series-title":"World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.humpath.2015.09.033_bb0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1309\/VD2D-98ME-MB3F-WH34","article-title":"Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma","volume":"118","author":"Xu","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1746-1596-7-7","article-title":"Secondary cutaneous Epstein-Barr virus\u2013associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of the literature","volume":"7","author":"Yang","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0020","first-page":"241","article-title":"Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic lymphoma","volume":"34","author":"Skugor","year":"2010","journal-title":"Coll Antropol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0025","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","article-title":"Epstein-Barr virus\u2013associated B-cell lymphoproliferative disorders in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified","volume":"117","author":"Zetti","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1440-1827.2012.02858.x","article-title":"Clinicopathological analysis of a composite lymphoma containing both T- and B-cell lymphomas","volume":"62","author":"Suefuji","year":"2012","journal-title":"Pathol Int"},{"key":"10.1016\/j.humpath.2015.09.033_bb0035","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0040","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma","volume":"121","author":"Dogan","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","article-title":"Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal center T-helper cells?","volume":"104","author":"Grogg","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2015.09.033_bb0050","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/modpathol.3800625","article-title":"Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified","volume":"19","author":"Grogg","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","article-title":"The frequency of B- and T-cell gene rearrangements in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations","volume":"8","author":"Tan","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2015.09.033_bb0060","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg\u2013like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0065","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exists","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0070","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcomes in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2015.09.033_bb0075","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of Myc and Bcl2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0080","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0085","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1309\/72CM-KAXF-66DE-4XVA","article-title":"Peripheral T-cell lymphomas complicated by a proliferation of large B cells","volume":"114","author":"Higgins","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0090","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"Van Dogen","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2015.09.033_bb0095","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2011.41.4342","article-title":"Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Green","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0100","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1200\/JCO.2011.41.0985","article-title":"Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone","volume":"30","author":"Johnson","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0105","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2012-10-460063","article-title":"MYC\/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2015.09.033_bb0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/PAS.0000000000000147","article-title":"Clinical significance of MYC expression and\/or \u201chigh-grade\u201d morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative study","volume":"38","author":"Cook","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0115","doi-asserted-by":"crossref","first-page":"e33813","DOI":"10.1371\/journal.pone.0033813","article-title":"Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas","volume":"7","author":"Kluk","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.09.033_bb0120","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.12763","article-title":"MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"165","author":"Perry","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0125","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1007\/s13277-014-1907-z","article-title":"MYC protein expression is associated with poor prognosis in diffuse large B cell lymphoma patients treated with RCHOP chemotherapy","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/PAS.0b013e318244e2ba","article-title":"High levels of nuclear MYC protein predict the presence of MYC rearrangement in diffuse large B-cell lymphoma","volume":"36","author":"Green","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.033_bb0135","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2013-07-517649","article-title":"Epstein-Barr virus latent membrane protein MYC-driven cell cycle progression in a mouse lymphoma","volume":"123","author":"Fish","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2015.09.033_bb0140","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.93.19.10411","article-title":"C-myc activation renders proliferation of Epstein-Barr virus (EBV)\u2013transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1","volume":"93","author":"Polack","year":"1996","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715003962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715003962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T23:14:34Z","timestamp":1567293274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715003962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":28,"alternative-id":["S0046817715003962"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.09.033","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}